In a Mount Sinai Study, Elevated Leukemia Incidence Is Found in World Trade Center Rescue and Recovery Workers
Overall cancer incidence also elevated, particularly in thyroid and prostate cancers.
NEW YORK, Jan. 15, 2020 /PRNewswire-PRWeb/ -- Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January.
Following the attacks on the World Trade Center, 50,000 workers were involved in rescue and recovery, with many of them caught directly in the dust cloud from the collapsing towers. From then until cleanup of the site ended in June 2002, workers were potentially exposed to an array of toxins later shown to cause adverse health effects, including cancer.
This study examined cancer incidence in responders including law enforcement, construction, and telecommunications workers, and found an increased overall cancer incidence, with the greatest elevation in thyroid cancer. It is the first to show an increase in leukemia, which is known to occur after exposure to occupational carcinogens, including benzene fuel and other sources that existed at the World Trade Center site, in some cases at low levels of exposure and with a latency of several years from exposure.
Researchers also found that neither the length of time that first responders and recovery workers worked on the World Trade Center site, nor the intensity of their exposure, had any bearing on the development of the elevated cancers. However, some risk factors—such as responders' age on September 11, their gender, and whether they were smokers at the time—were associated with increased cancer risk, underlining the need for continued surveillance of World Trade Center rescue and recovery workers.
"This study showed increased incidence of several cancer types compared to previously conducted studies with shorter follow-up periods," said Susan Teitelbaum, PhD, Professor of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai and one of the lead authors. "Because of the long latency period of many types of cancer, it is possible that increased rates of other cancers, as well as World Trade Center exposure health issues, may emerge after longer periods of study."
Researchers studied post-September 11 cancer incidence among 28,729 rescue and recovery workers via cancer registry data from New York, New Jersey, Connecticut, Pennsylvania, Florida, and North Carolina from 2002 through 2013. Although the incidence of certain cancers, such as lung, was not elevated in this study's findings, researchers believe that may be due to the long time periods over which these cancers develop.
This work was supported by contract 200-2017-93325 from the Centers for Disease Control and Prevention / National Institute for Occupational Safety & Health.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
SOURCE Mount Sinai Health System
Share this article